Work

170 P Phase II trial of lnterferon-γ (LFN-γ)/interleukln-2 (1L-2) for advanced renal cell carcinoma (RCC)

Year: 1996

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/0959-8049(96)84923-9

Authors: M.P. Djavanmard, G.G. Steger, A.C. Budinsky, I. Michl, B. Steiner, T. Brodowicz, M. Krainer, B. Blöchl-Dawn, H. Huber, M. Marberger, C.C. Ziehnski

Institutions: University of Vienna, Medical University of Vienna

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1983965249

FWCI:

Cites:

Cited by:

Related to: 10